Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 4
1980 3
1984 1
1987 1
1988 1
1989 3
1990 3
1991 2
1993 1
2005 1
2006 1
2008 3
2012 1
2013 1
2014 2
2015 1
2016 2
2017 1
2018 1
2020 1
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

34 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial.
Vilgrain V, Pereira H, Assenat E, Guiu B, Ilonca AD, Pageaux GP, Sibert A, Bouattour M, Lebtahi R, Allaham W, Barraud H, Laurent V, Mathias E, Bronowicki JP, Tasu JP, Perdrisot R, Silvain C, Gerolami R, Mundler O, Seitz JF, Vidal V, Aubé C, Oberti F, Couturier O, Brenot-Rossi I, Raoul JL, Sarran A, Costentin C, Itti E, Luciani A, Adam R, Lewin M, Samuel D, Ronot M, Dinut A, Castera L, Chatellier G; SARAH Trial Group. Vilgrain V, et al. Among authors: perdrisot r. Lancet Oncol. 2017 Dec;18(12):1624-1636. doi: 10.1016/S1470-2045(17)30683-6. Epub 2017 Oct 26. Lancet Oncol. 2017. PMID: 29107679 Clinical Trial.
Pathophysiological roles of G-protein-coupled receptor kinases.
Métayé T, Gibelin H, Perdrisot R, Kraimps JL. Métayé T, et al. Among authors: perdrisot r. Cell Signal. 2005 Aug;17(8):917-28. doi: 10.1016/j.cellsig.2005.01.002. Epub 2005 Feb 17. Cell Signal. 2005. PMID: 15894165 Review.
[GRKs and arrestins: the therapeutic pathway?].
Métayé T, Perdrisot R, Kraimps JL. Métayé T, et al. Among authors: perdrisot r. Med Sci (Paris). 2006 May;22(5):537-43. doi: 10.1051/medsci/2006225537. Med Sci (Paris). 2006. PMID: 16687124 Free article. Review. French.
FFCD 1709-SIRTCI phase II trial: Selective internal radiation therapy plus Xelox, Bevacizumab and Atezolizumab in liver-dominant metastatic colorectal cancer.
Randrian V, Pernot S, Le Malicot K, Catena V, Baumgaertner I, Tacher V, Forestier J, Hautefeuille V, Tabouret-Viaud C, Gagnaire A, Mitry E, Guiu B, Aparicio T, Smith D, Dhomps A, Tasu JP, Perdrisot R, Edeline J, Capron C, Cheze-Le Rest C, Emile JF, Laurent-Puig P, Bejan-Angoulvant T, Sokol H, Lepage C, Taieb J, Tougeron D. Randrian V, et al. Among authors: perdrisot r. Dig Liver Dis. 2022 Jul;54(7):857-863. doi: 10.1016/j.dld.2022.04.024. Epub 2022 May 21. Dig Liver Dis. 2022. PMID: 35610167 Free article. Clinical Trial.
34 results